What happened
SK biopharmaceuticals disclosed a supply contract with SK Life Science,Inc., worth US$70.3M, about 14.1% of its recent annual revenue, running through Aug 2026.
For context, this single contract equals about 14.1% of the company's most recent annual revenue.
| Counterparty | SK Life Science,Inc. |
|---|---|
| Contract value | US$70.3M |
| vs. recent revenue | 14.1% |
| Through | Aug 2026 (from Aug 2026) |
| Filed | 2026-08-18, Supply contract signed |
| Source | DART rcept 20260818800303 → open original filing |
Source: DART. Information only, not investment advice.